✦ LIBER ✦

High-dose intravenous immunoglobulin in the treatment of Guillain-Barré syndrome: a preliminary open study

✍ Scribed by Matthew C. Jackson; Richard B. Godwin-Austen; Alan M. Whiteley

Publisher: Springer
Year: 1993
Tongue: English
Weight: 274 KB
Volume: 240
Category: Article
ISSN: 0340-5354
DOI: 10.1007/bf00838447

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Treatment of Guillain-Barré syndrome wit

Treatment of Guillain-Barré syndrome with high-dose immune globulins combined with methylprednisolone: A pilot study

📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 407 KB 👁 1 views

Blockade of blocking antibodies in Guill

Blockade of blocking antibodies in Guillain-Barré syndromes: “Unblocking” the mystery of action of intravenous immunoglobulin

✍ Marinos C. Dalakas 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 57 KB 👁 1 views

Is there a scientific rationale for ther

Is there a scientific rationale for therapeutic plasma exchange or intravenous immune globulin in the treatment of acute guillain-barré syndrome?

✍ Robert Weinstein 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 836 KB

## IMMUNE MODULATION AND PLASMA EXCHANGE Transferable Serum Factors In 1971, Stuart Cook and colleagues reported that sera from 26 of 31 patients with Guillain-Barre syndrome caused complement-dependent demyelination of living

A randomized study of 2 dose levels of i

A randomized study of 2 dose levels of intravenous clofarabine in the treatment of patients with higher-risk myelodysplastic syndrome

✍ Stefan Faderl; Guillermo Garcia-Manero; Elias Jabbour; Farhad Ravandi; Gautam Bo 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 181 KB 👁 1 views

## Abstract ## BACKGROUND: Clofarabine is a nucleoside analog with activity in myeloid malignancies. Experience in myelodysplastic syndrome (MDS) is limited. ## METHODS: The goal of this study was to evaluate the activity and safety of 2 different doses (15 mg/m^2^ vs 30 mg/m^2^ daily × 5 days)